In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations

Blood

Volumn 106, Issue 10, 2005, Pages 3602-3608

  Silverman, Lee R ^b   Phipps, Andrew J ^b   Montgomery, Andy ^b   Fernandez, Soledad ^b   Tsukahara, Tomonori ^b   Ratner, Lee ^b   Lairmore, Michael D ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; VIRUS ANTIGEN; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; HUMAN T CELL LEUKEMIA VIRUS 1; HUMORAL IMMUNITY; IN VITRO STUDY; INOCULATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL; PROVIRUS; RABBIT; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS MUTANT; VIRUS REPLICATION; WILD TYPE;

EID: 27744598788     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-03-1076     Document Type: Article

References (47)

1. Mahieux R, Gessain A. HTLV-1 and associated adult T-cell leukemia/lymphoma. Rev Clin Exp Hematol. 2003;7:336-361.
2. Yamaguchi K, Takatsuki K. Adult T cell leukaemia-lymphoma. Clin Haematol. 1993;6:899-915.
3. Shimoyama M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemialymphoma. A report from the Lymphoma Study Group (1984-87). Br J Haematol. 1991;79:428-437.
4. Mueller NE, Blattner WA. Retroviruses: human T-cell lymphotropic virus. In: Evans AS and Kaslow RA, eds. Viral Infections of Humans: Epidemiology and Control. 4th ed. New York, NY: Plenum Publishing Corporation; 1997:785-814.
5. De BK, Lairmore MD, Griffis K, et al. Comparative analysis of nucleotide sequences of the partial envelope gene (5′ domain) among human T lymphotropic virus type I (HTLV-I) isolates. Virology. 1991;182:413-419.
6. Daenke S, Nightingale S, Cruickshank JK, Bangham CRM. Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates. J Virol. 1990;64:1278-1282.
7. Seiki M, Hattori S, Hirayama Y, Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc Natl Acad Sci. 1983;80:3618-3622.
8. Tsujimoto A, Teruuchi T, Imamura J, et al. Nucleotide sequence analysis of a provirus derived from HTLV-1-associated myelopathy (HAM). Mol Biol Med. 1988;5:29-42.
9. Malik KT, Even J, Karpas A. Molecular cloning and complete nucleotide sequence of an adult T cell leukaemia virus/human T cell leukaemia virus type I (ATLV/HTLV-I) isolate of Caribbean origin: relationship to other members of the ATLV/HTLV-I subgroup. J Gen Virol. 1988;69(pt 7):1695-1710.
10. Pique C, Dokhelar MC. The HTLV-1 envelope: an overview. In: Haseltine WA, Wongstaal F, eds. Genetic Structure and Regulation of HIV. New York, NY: Raven Press, Ltd; 1991:499-510.
11. Hattori S, Kiyokawa T, Imagawa K, et al. Identification of gag and env gene products of human T-cell leukemia virus (HTLV). Virology. 1984;136:338-347.
12. Lee TH, Coligan JE, Homma T, et al. Human T-cell leukemia virus-associated membrane antigens: identity of the major antigens recognized after virus infection. Proc Natl Acad Sci U S A. 1984;81:3856-3860.
13. Manel N, Kim FJ, Kinet S, et al. The ubiquitous glucose transporter GLUT-1 is a receptor for HTLV. Cell. 2003;115:449-459.
14. Delamarre L, Rosenberg AR, Pique C, et al. The HTLV-I envelope glycoproteins: structure and functions. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(suppl 1):S85-S91.
15. Astier-Gin T, Portail JP, Londos-Gagliardi D, et al. Neutralizing activity and antibody reactivity toward immunogenic regions of the human T cell leukemia virus type I surface glycoprotein in sera of infected patients with different clinical states. J Infect Dis. 1997;175:716-719.
16. Palker T, Tanner M, Scearce R, et al. Mapping of immunogenic regions of human T-cell leukemia virus type 1 (HTLV-I) gp46 and gp21 envelope glycoproteins with Env-encoded synthetic peptides and a monoclonal antibody to gp46. J Immunol. 1989;142:971-978.
17. Baba E, Nakamura M, Tanaka Y, et al. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-I) identified by human monoclonal antibodies: a basis for the design of an HTLV-1 peptide vaccine. J Immunol. 1993;151:1013-1024.
18. Kuroki M, Nakamura M, Itoyama Y, et al. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T-cell leukemia virus type 1. J Immunol. 1992;149:940-948.
19. Tanaka Y, Tanaka R, Terada E, et al. Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization. J Virol. 1994;68:6323-6331.
20. Delamarre L, Pique C, Pham D, Tursz T, Dokhelar MC. Identification of functional regions in the human T-cell leukemia virus type I SU glycoprotein. J Virol. 1994;68:3544-3549.
21. Le Blanc I, Grange MP, Delamarre L, et al. HTLV-1 structural proteins. Virus Res. 2001;78:5-16.
22. Pique C, Tursz T, Dokhelar MC. Mutations introduced along the HTLV-I envelope gene result in a non functional protein: a basis for envelope conservation? EMBO J. 1990;9:4243-4248.
23. Delamarre L, Rosenberg AR, Pique C, Pham D, Dokhelar MC. A novel human T-leukemia virus type 1 cell-to-cell transmission assay permits definition of SU glycoprotein amino acids important for infectivity. J Virol. 1997;71:259-266.
24. Rosenberg JR, Delamarre L, Pique C, Pham D, Dokhelar MC. The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events. J Virol. 1997;71:7180-7186.
25. Kimata JT, Wong F, Wang J, Ratner L. Construction and characterization of infectious human T-cell leukemia virus type 1 molecular clones. Virology. 1994;204:656-664.
26. Bartoe JT, Albrecht B, Collins ND, et al. Functional role of pX open reading frame II of human T-lymphotropic virus type 1 in maintenance of viral loads in vivo. J Virol. 2000;74:1094-1100.
27. Collins ND, Newbound GC, Albrecht B, et al. Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. Blood. 1998;91:4701-4707.
28. Silverman LR, Phipps AJ, Montgomery A, Ratner L, Lairmore MD. Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion. J Virol. 2004;78:3837-3845.
29. Ye J, Silverman L, Lairmore MD, Green PL. HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro. Blood. 2003;102:3963-3969.
30. Tsukahara T, Wielgosz MM, Ratner L. Characterization of envelope glycoprotein mutants for human T-cell leukemia virus type 1 infectivity and immortalization. J Virol. 2001;75:9553-9559.
31. Collins ND, Newbound GC, Ratner L, Lairmore MD. In vitro CD4(+) lymphocyte transformation and infection in a rabbit model with a molecular clone of human T-cell lymphotropic virus type 1. J Virol. 1996;70:7241-7246.
32. Miley WJ, Suryanarayana K, Manns A, et al. Real-time polymerase chain reaction assay for cell-associated HTLV type I DNA viral load. AIDS Res Hum Retroviruses. 2000;16:665-675.
33. Blanchard S, Astier-Gin T, Tallet B, et al. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies. J Virol. 1999;73:9369-9376.
34. Tanaka Y, Zeng L, Shiraki H, Shida H, Tozawa H. Identification of a neutralization epitope on the envelope gp46 antigen of human T-cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. J Immunol. 1991;147:354-360.
35. Gabet AS, Gessain A, Wattel E. High simian T-cell leukemia virus type 1 proviral loads combined with genetic stability as a result of cell-associated provirus replication in naturally infected, asymptomatic monkeys. Int J Cancer. 2003;107:74-83.
36. Hashimoto K, Higuchi I, Osame M, Izumo S. Quantitative in situ PCR assay of HTLV-1 infected cells in peripheral blood lymphocytes of patients with ATL, HAM/TSP and asymptomatic carriers. J Neurol Sci. 1998;159:67-72.
37. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. J Neurovirol. 1998;4:586-593.
38. Shinzato O, Ikeda S, Momita S, et al. Semiquantitative analysis of integrated genomes of human T-lymphotropic virus type I in asymptomatic virus carriers. Blood. 1991;78:2082-2088.
39. Kamihira S, Dateki N, Sugahara K, et al. Significance of HTLV-1 proviral load quantification by real-time PCR as a surrogate marker for HTLV-1-infected cell count. Clin Lab Haematol. 2003;25:111-117.
40. Segurado AA, Malaque CM, Sumita LM, Pannuti CS, Lal RB. Laboratory characterization of human T cell lymphotropic virus types 1 (HTLV-1) and 2 (HTLV-2) infections in blood donors from Sao Paulo, Brazil. Am J Trop Med Hyg. 1997;57:142-148.
41. Pancake BA, Zucker-Franklin D, Marmor M, Legler PM. Determination of the true prevalence of infection with the human T-cell lymphotropic viruses (HTLV-I/II) may require a combination of biomolecular and serological analyses. Proc Assoc Am Physicians. 1996;108:444-448.
42. Liu H, Shah M, Stramer SL, et al. Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II. Transfusion. 1999;39:1185-1193.
43. Hartley TM, Khabbaz RF, Cannon RO, Kaplan JE, Lairmore MD. Characterization of antibody reactivity to human T-cell lymphotropic virus types I and II using immunoblot and radioimmunoprecipitation assays. J Clin Microbiol. 1990;28:646-650.
44. Khabbaz RF, Onorato IM, Cannon RO, et al. Seroprevalence of HTLV-1 and HTLV-2 among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med. 1992;326:375-380.
45. Yang YC, Hsu TY, Liu MY, et al. Molecular subtyping of human T-lymphotropic virus type I (HTLV- I) by a nested polymerase chain reaction-restriction fragment length polymorphism analysis of the envelope gene: two distinct lineages of HTLV-I in Taiwan. J Med Virol. 1997;51:25-31.
46. Mortreux F, Gabet AS, Wattel E. Molecular and cellular aspects of HTLV-1 associated leukemogenesis in vivo. Leukemia. 2003;17:26-38.
47. Mortreux F, Leclercq I, Gabet AS, et al. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst. 2001;93:367-377.